Path sampling challenges in large biomolecular systems: RETIS and REPPTIS for ABL-imatinib kinetics

Wouter Vervust1, Daniel T Zhang2, Enrico Riccardi3

  • 1IBiTech - BioMMedA Research Group, Ghent University, Gent, Belgium.

Biophysical Journal
|April 25, 2025
PubMed
Summary

Predicting drug-protein interaction kinetics is vital for personalized medicine. This study used path sampling to analyze imatinib dissociation from Abelson kinase, facing challenges with complex energy landscapes and convergence for improved drug efficacy predictions.